NCBI on safety study of meloxicam

Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac. Furst DE1, Kolba KS, Fleischmann R, Silverfield J, Greenwald M, Roth S,...

Read More

Parkinson Disease and Sifrol

  Abstract Pramipexole, the most commonly prescribed dopamine agonist worldwide, meanwhile serves as a reference substance for evaluation of new drugs. Based on numerous clinical data and vast experiences, efficacy and safety profiles of this non-ergoline dopamine agonist are well...

Read More

1 Al-Mosher Ahmed Ismail St. Heliopolis, Cairo, Egypt Sheraton 2nd Floor, No. 44

Call Us Now at

Call Us Now at

(202) 22685092

Email Us at

Email Us at

info@polypharm-eg.com

PolyPharm

PolyPharm

About Us